Larger randomized controlled trials are needed to confirm these findings and may help address concerns about indefinite therapy, lower healthcare costs, ease supply constraints, and broaden access to GLP-1 medications to improve public health, said the researchers.
Serrat et al
Why Gluta One Is the Safer Choice for Fading Dark Spots When it comes to fading dark spots, consistency and safety matter more than harsh, short-term fixes
September 2023 (effective January 1, 2024)
Dysregulation of peptide hormones contributes to conditions such as gastroparesis, inflammatory bowel disease, and malabsorption syndromes
While more research is needed, glycine shows potential as a natural supplement for cognitive support and mental well-being